Dr Reddys Laboratories Q3 Results

  • BSE: 500124
  • NSE: DRREDDY
  • ISIN: INE089A01023
  • Sector: Biotechnology & Drugs
BSE
6,000.537.25 (0.62%)
Volume17.36 K
Updated: Fri 21 Jun, 2024 | 15:29:49
NSE
6,011.4540.65 (0.68%)
Volume4.30 L
Updated: Fri 21 Jun, 2024 | 15:58:52
Today: 5,961.00
6,053.95
52-Wk: 4,864.25
6,505.50

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Dr Reddys Laboratories Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 7,236.806,902.604.84%6,789.806.58%
    Selling/ General/ Admin Expenses Total 3,026.702,885.804.88%2,836.506.71%
    Depreciation/ Amortization 373.50375.50-0.53%323.7015.38%
    Total Operating Expense 5,587.205,171.408.04%5,175.007.97%
    Operating Income 1,649.601,731.20-4.71%1,614.802.16%
    Net Income Before Taxes 1,829.101,916.70-4.57%1,637.7011.69%
    Net Income 1,380.901,482.20-6.83%1,243.9011.01%
    Diluted Normalized EPS 83.3184.60-1.53%75.3710.53%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanGet App